4.11. Analysis.
Comparison 4 Inotersen versus placebo in TTR‐FAP, Outcome 11 Number of participants experiencing at least one severe adverse event related to the study medication.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.